Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy
- At: Seville (Spain) (2022)
- Type: Digital
- By: CHEN, Pei-chun (Taipei City Hospital Yangming Branch, China Taiwan)
- Co-author(s): Ms Pei-chun Chen (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
Mr. Kai-Hsiang Yang, Pharmacy (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
Background information: The medicinal product Ceftazidime-Avibactam (Zavicefta®) is first-line therapy for the treatment of refractory infections caused by Gram-negative bacilli.
Purpose: The purpose of this study was to evaluate the efficacy and adverse effects of Ceftazidime-Avibactam combined with other antibiotics and Ceftazidime-Avibactam.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019